Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center

Warning LetterClosed

United StatesFEI 3006089725Issued Apr 4, 2018

View FDA's record for FEI 3006089725

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3006089725.

Violations0

Issue DateApr 4, 2018

Product TypeOther

StatusClosed

Letter Details

Firm: Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center
Location: United States
FEI Number: 3006089725
Country: United States
Issue Date: April 04, 2018
Issuing Office: N/A
Product Type: Other
Status: Closed

Summary

Based on limited metadata, the FDA issued a Warning Letter to Puget Sound Drug Corporation, operating as Key Pharmacy and Compounding Center, on April 4, 2018. The letter addresses violations related to a pharmacy compounding operation, though the specific nature of the violations cannot be determined without access to the full letter text. The regulatory action falls under FDA oversight of compounding pharmacies, which are subject to standards for pharmaceutical manufacturing and quality control. Additional details regarding the specific violations and regulatory requirements cited would require review of the complete Warning Letter.

Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center FDA Warning Letter, April 4, 2018